Medicinal Products

Soliris

Name Soliris
Active Substance eculizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L04AA25
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za propisivače PNH, verzija 4
Vodič za propisivace aHUS, verzija 4
Vodič za propisivace gMG, verzija 3
Educational materials
for patients / caregivers
Brošura za bolesnike oboljele od PNH i roditelje, verzija 4
Brošura za roditelje djece i dojenčadi oboljele od PNH, verzija 2
Brošura za bolesnike oboljele od aHUS i roditelje, verzija 4
Brošura za roditelje male djece i dojenčadi oboljele od aHUS, verzija 2
Brošura za bolesnike oboljele od gMG, verzija 3
Kartica sa sigurnosnim informacijama za bolesnika, verzija 3

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/soliris

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back